EE05341B1 - Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek - Google Patents

Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek

Info

Publication number
EE05341B1
EE05341B1 EEP200800027A EEP200800027A EE05341B1 EE 05341 B1 EE05341 B1 EE 05341B1 EE P200800027 A EEP200800027 A EE P200800027A EE P200800027 A EEP200800027 A EE P200800027A EE 05341 B1 EE05341 B1 EE 05341B1
Authority
EE
Estonia
Prior art keywords
microorganism
plantarum inducia
ldl
enhances
blood
Prior art date
Application number
EEP200800027A
Other languages
English (en)
Estonian (et)
Inventor
Mikelsaar Marika
Songisepp Epp
Smidt Imbi
Stsepetova Jelena
H�tt Pirje
Zilmer Mihkel
Truusalu Kai
Kilk Kalle
Original Assignee
O� Tervisliku Piima Biotehnoloogiate Arenduskeskus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by O� Tervisliku Piima Biotehnoloogiate Arenduskeskus filed Critical O� Tervisliku Piima Biotehnoloogiate Arenduskeskus
Priority to EEP200800027A priority Critical patent/EE05341B1/xx
Priority to EP09745475A priority patent/EP2288360B1/en
Priority to RU2010147343/10A priority patent/RU2486234C2/ru
Priority to PL09745475T priority patent/PL2288360T3/pl
Priority to AT09745475T priority patent/ATE536879T1/de
Priority to PCT/EE2009/000006 priority patent/WO2009138092A1/en
Priority to US12/992,862 priority patent/US20110274789A1/en
Priority to KR1020107028014A priority patent/KR101595042B1/ko
Priority to DK09745475.5T priority patent/DK2288360T3/da
Publication of EE200800027A publication Critical patent/EE200800027A/xx
Publication of EE05341B1 publication Critical patent/EE05341B1/xx
Priority to US14/244,284 priority patent/US20140335066A1/en
Priority to EEP201800005A priority patent/EE05809B1/et
Priority to EP14799963.5A priority patent/EP3193895B1/en
Priority to LTEP14799963.5T priority patent/LT3193895T/lt
Priority to DK14799963.5T priority patent/DK3193895T3/da
Priority to US15/132,286 priority patent/US10272122B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/061—Addition of, or treatment with, microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/06—Treating cheese curd after whey separation; Products obtained thereby
    • A23C19/061—Addition of, or treatment with, microorganisms
    • A23C19/062—Addition of, or treatment with, microorganisms using only lactic acid bacteria, e.g. pediococcus, leconostoc or bifidus sp., or propionic acid bacteria; Treatment with non-specified acidifying bacterial cultures
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/05—Treating milk before coagulation; Separating whey from curd
    • A23C19/054—Treating milk before coagulation; Separating whey from curd using additives other than acidifying agents, NaCl, CaCl2, dairy products, proteins, fats, enzymes or microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Physiology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EEP200800027A 2008-05-13 2008-05-13 Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek EE05341B1 (et)

Priority Applications (15)

Application Number Priority Date Filing Date Title
EEP200800027A EE05341B1 (et) 2008-05-13 2008-05-13 Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
KR1020107028014A KR101595042B1 (ko) 2008-05-13 2009-05-12 자연 면역을 증가시키는 프로바이오틱인 단리된 락토바실러스 플란타룸 균주 인듀시아 ｄｓｍ 21379와, 이를 포함하는 식품과 의약적 제제
DK09745475.5T DK2288360T3 (da) 2008-05-13 2009-05-12 Isoleret Lactobacillus plantarum-stamme Inducia DSM21379 som probiotikum, som forøger naturlig immunitet, samt fødevareprodukter og medicinske præparater omfattende den
PL09745475T PL2288360T3 (pl) 2008-05-13 2009-05-12 Izolowany szczep Lactobacillus plantarum Inducia dsm 21379 jako probiotyk wzmacniający naturalną odporność oraz zawierające go produkty spożywcze i preparaty medyczne
AT09745475T ATE536879T1 (de) 2008-05-13 2009-05-12 Isoliertes lactobacillus-plantarum-stamm-inducia dsm 21379 als probiotikum zur verbesserung der natürlichen immunität und dieses umfassende nahrungsprodukte und medizinische zubereitungen
PCT/EE2009/000006 WO2009138092A1 (en) 2008-05-13 2009-05-12 Isolated lactobacillus plantarum strain inducia dsm 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it
US12/992,862 US20110274789A1 (en) 2008-05-13 2009-05-12 Isolated lactobacillus plantarum strain inducia dsm 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it
EP09745475A EP2288360B1 (en) 2008-05-13 2009-05-12 Isolated lactobacillus plantarum strain inducia dsm 21379 as probiotic that enhances natural immunity and food products and medicinal preparations comprising it
RU2010147343/10A RU2486234C2 (ru) 2008-05-13 2009-05-12 ИЗОЛИРОВАННЫЙ ШТАММ МИКРООРГАНИЗМА Lactobacillus plantarum Inducia DSM 21379 В КАЧЕСТВЕ ПРОБИОТИКА, УСИЛИВАЮЩЕГО ВРОЖДЕННЫЙ ИММУНИТЕТ ОРГАНИЗМА, ПРОДУКТ И КОМПОЗИЦИЯ, СОДЕРЖАЩИЕ УПОМЯНУТЫЙ МИКРООРГАНИЗМ, И ПРИМЕНЕНИЕ УПОМЯНУТОГО МИКРООРГАНИЗМА ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННОГО СРЕДСТВА, КОТОРОЕ УСИЛИВАЕТ КЛЕТОЧНЫЙ ИММУНИТЕТ
US14/244,284 US20140335066A1 (en) 2008-05-13 2014-04-03 Lactobacillus plantarum inducia dsm 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against clostridium difficile
EEP201800005A EE05809B1 (et) 2008-05-13 2014-10-31 Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks
EP14799963.5A EP3193895B1 (en) 2008-05-13 2014-10-31 Lactobacillus plantarum inducia strain dsm 21379 as hypocholesterolemic agent and antimicrobial agent against clostridium difficile
LTEP14799963.5T LT3193895T (lt) 2008-05-13 2014-10-31 Lactobacillus plantarum inducia padermė dsm21379, kaip hipocholesteroleminis agentas ir antimikrobinis agentas nuo clostridium difficile
DK14799963.5T DK3193895T3 (da) 2008-05-13 2014-10-31 Lactobacillus plantarum-stamme inducia dsm 21379 som hypocholesterolæmisk middel og antimikrobielt middel mod clostridium difficile
US15/132,286 US10272122B2 (en) 2008-05-13 2016-04-19 Lactobacillus plantarum inducia DSM 21379 as enhancer of cellular immunity, hypocholesterolemic and anti-oxidative agent and antimicrobial agent against Clostridium difficile

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EEP200800027A EE05341B1 (et) 2008-05-13 2008-05-13 Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek

Publications (2)

Publication Number Publication Date
EE200800027A EE200800027A (et) 2009-12-15
EE05341B1 true EE05341B1 (et) 2010-08-16

Family

ID=40957913

Family Applications (2)

Application Number Title Priority Date Filing Date
EEP200800027A EE05341B1 (et) 2008-05-13 2008-05-13 Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
EEP201800005A EE05809B1 (et) 2008-05-13 2014-10-31 Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks

Family Applications After (1)

Application Number Title Priority Date Filing Date
EEP201800005A EE05809B1 (et) 2008-05-13 2014-10-31 Probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks Clostridium difficile põhjustatud kõhulahtisuse (CDAD) riski vähendamiseks

Country Status (10)

Country Link
US (3) US20110274789A1 (xx)
EP (2) EP2288360B1 (xx)
KR (1) KR101595042B1 (xx)
AT (1) ATE536879T1 (xx)
DK (2) DK2288360T3 (xx)
EE (2) EE05341B1 (xx)
LT (1) LT3193895T (xx)
PL (1) PL2288360T3 (xx)
RU (1) RU2486234C2 (xx)
WO (1) WO2009138092A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
FR2955774A1 (fr) 2010-02-02 2011-08-05 Aragan Preparation destinee a traiter l'exces ponderal et les desordres associes et applications de ladite preparation
ES2402014B1 (es) 2011-09-07 2014-02-27 Consejo Superior De Investigaciones Científicas (Csic) Peptido secretado por lactobacillus plantarum con función inmunomoduladora
EP2794930B1 (en) * 2011-12-21 2016-07-27 Compagnie Gervais Danone Novel strain of lactobacillus mucosae
WO2015081263A1 (en) 2013-11-26 2015-06-04 Central Biomedia, Inc. Method and diet for immune enhanced donor blood
WO2015146916A1 (ja) * 2014-03-24 2015-10-01 大塚製薬株式会社 新規ラクトバチラス・パラカゼイ株
JP2017515799A (ja) * 2014-04-03 2017-06-15 オウ テルヴィスリク ピーマ バイオテウノロジーテ アレンダスケスクス コレステロール低下剤およびクロストリジウム・ディフィシレに対する抗微生物剤としてのラクトバチルス・プランタルムＩｎｄｕｃｉａ株ＤＳＭ２１３７９
ES2764210T3 (es) * 2014-11-25 2020-06-02 Dsm Ip Assets Bv Lactobacillus para usar como probiótico
RU2567149C1 (ru) * 2014-12-24 2015-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Горский государственный аграрный университет" ШТАММ Lactobacillus plantarum, ИСПОЛЬЗУЕМЫЙ ДЛЯ ПОЛУЧЕНИЯ КИСЛОМОЛОЧНЫХ ПРОДУКТОВ И ПРОБИОТИЧЕСКИХ ПРЕПАРАТОВ
KR101675035B1 (ko) * 2015-07-17 2016-11-22 주식회사 빙그레 락토바실러스 속 균주를 포함하는 생균제 조성물, 동물사료용 첨가제 및 동물사료 조성물
US9730969B2 (en) 2015-11-06 2017-08-15 Mead Johnson Nutrition Company Nutritional compositions for promoting gut barrier function and ameliorating visceral pain
KR101794772B1 (ko) * 2016-06-08 2017-12-01 강원대학교산학협력단 폴리아민 고생산 신균주 바실러스 서브틸리스 ee5 균주
US10166262B2 (en) 2017-04-20 2019-01-01 Ewelina Sosnowska-Turek Strain of bacteria and composition comprising the same
KR102486970B1 (ko) * 2017-09-22 2023-01-10 주식회사 고바이오랩 클로스트리디움 디피실레(Clostridium difficile) 성장 억제효과를 갖는 락토바실러스 균주
TWI740101B (zh) * 2019-02-12 2021-09-21 大江生醫股份有限公司 降膽固醇之益生菌株的用途
SK502019A3 (sk) * 2019-05-15 2020-12-02 Labas Miroslav Spôsob výroby mlieka a mliečnych doplnkov s unikátnym zložením mastných kyselín obnovovaním komenzálnej prirodzenej mikrobioty
EP4132492A1 (en) * 2020-04-07 2023-02-15 Kalin Health LLC Spermidine-supplemented food products
KR102363975B1 (ko) * 2020-12-11 2022-02-17 주식회사 바이오뱅크힐링 락토바실러스 플란타룸 균주, 및 그의 유래의 소포체 및 그의 항염증 및 항균 용도
CN112553115B (zh) * 2020-12-23 2022-09-16 南昌大学 植物乳杆菌zdy2013在制备缓解肾损伤产品中应用
CN113881604B (zh) * 2021-11-10 2023-02-28 深圳大学 一株植物乳杆菌mm89及其多糖和应用
CN115381005B (zh) * 2022-08-25 2023-09-19 中国农业科学院饲料研究所 植物乳杆菌cicc 6240在消减水产品体内抗生素残留中的应用
CN117417847B (zh) * 2023-08-22 2024-03-15 大理大学 一种大理梭菌及其在制备抗氧化功能性物质中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5895758A (en) * 1997-06-10 1999-04-20 Bio-Energy Systems Strain of lactobacillus Plantarum
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IL153956A0 (en) * 2000-08-11 2003-07-31 Whitlock David R Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
GB2369777B (en) * 2000-10-05 2004-10-27 St Ivel Ltd Food products with antimicrobial lactic acid bacteria
ITMI20020399A1 (it) 2002-02-28 2003-08-28 Ct Sperimentale Del Latte S P Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
ATE409220T1 (de) * 2002-03-21 2008-10-15 Bifodan As Lactobacillus-stämme
RU2247148C2 (ru) * 2002-05-28 2005-02-27 Пименов Евгений Васильевич Штамм бактерий lactobacillus plantarum p4, штамм бактерий lactobacillus buchneri p0 и препарат-пробиотик на их основе для коррекции дисбактериозов различной этиологии у людей и животных
WO2004076615A2 (en) * 2003-02-27 2004-09-10 Bioneer A/S Immunomodulating probiotic compounds
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product
FR2898014B1 (fr) * 2006-03-03 2008-09-12 Gervais Danone Sa Procede de fabrication d'un dessert glace et dessert glace ainsi obtenu
EE05340B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Tensia DSM 21380 ja selle kasutamine antimikroobse ning verer?hku alandava probiootikuna ning ravimi valmistamiseks ning toiduaine realiseerimisaja pikendamiseks ja toiduaines kontamineerivatemi
EE05341B1 (et) * 2008-05-13 2010-08-16 O� Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
EP2311473A1 (en) * 2009-10-09 2011-04-20 AB-Biotics Producciones Industriales De Microbiotas, S.L. Lactobacillus plantarum strains as probiotics

Also Published As

Publication number Publication date
EP2288360B1 (en) 2011-12-14
EE201800005A (et) 2018-07-16
WO2009138092A1 (en) 2009-11-19
EP2288360A1 (en) 2011-03-02
US10272122B2 (en) 2019-04-30
US20140335066A1 (en) 2014-11-13
EP3193895A1 (en) 2017-07-26
US20110274789A1 (en) 2011-11-10
LT3193895T (lt) 2020-07-27
RU2010147343A (ru) 2012-06-20
KR101595042B1 (ko) 2016-02-17
RU2486234C2 (ru) 2013-06-27
PL2288360T3 (pl) 2012-06-29
US20160296570A1 (en) 2016-10-13
EE05809B1 (et) 2018-09-17
DK2288360T3 (da) 2012-03-19
DK3193895T3 (da) 2020-07-20
EE200800027A (et) 2009-12-15
KR20110018898A (ko) 2011-02-24
ATE536879T1 (de) 2011-12-15
EP3193895B1 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
EE05341B1 (et) Isoleeritud mikroorganismi tvi Lactobacillus plantarum Inducia DSM 21379 kui organismi loomulikku kaitsev?imet t?stev probiootik, seda sisaldav toiduaine ja kompositsioon ning mikroorganismi kasutamine rakulist immuunsust t?stva ravimi valmistamisek
EE201400038A (et) Hüpokolestereemilist ja antimikroobset agenti probiootilist mikroorganismi tüve Lactobacillus plantarum Inducia DSM 21379 sisaldav kompositsioon kasutamiseks südame-veresoonkonnahaiguste ja Clostridium difficile põhjustatava kõhulahtisuse ennetamisek
Rathore et al. Production of potentially probiotic beverages using single and mixed cereal substrates fermented with lactic acid bacteria cultures
Powell et al. Characterization of bacteriocin ST8KF produced by a kefir isolate Lactobacillus plantarum ST8KF
Agil et al. Lentils enhance probiotic growth in yogurt and provide added benefit of antioxidant protection
Di Sotto et al. Antimutagenic and mutagenic activities of some terpenes in the bacterial reverse mutation assay
TW200806194A (en) Preparation method of fermented fruits and vegetables, fermented fruits and vegetables prepared thereby and functional composition comprising the same
MX2010007338A (es) Composiciones comestibles.
WO2009142472A3 (es) Bifidobacteria productora de ácido fólico, composición alimenticia y uso de la bifidobacteria
NO20085170L (no) Fremgangsmate for utvidelse av lagringsbestandigheten av pulverformige naeringsformuleringer inneholdende levedyktige probiotiske midler
Bartkiene et al. Lactic acid fermentation of tomato: Effects on cis/trans lycopene isomer ratio, β-carotene mass fraction and formation of L (+)-and D (–)-lactic acid
NZ591040A (en) Method for treating feed silage for ruminants by treatment with at least two microbes selected from specific Lactobacillus, Enterococcus, Trichosporon strains
MY160508A (en) Lactobacillus plantarum strains as hypocholesterolemic agents
Di Cagno et al. Vegetable and fruit fermentation by lactic acid bacteria
JP2008179601A5 (xx)
Ehsani et al. Effects of Mentha longifolia L. essential oil and Lactobacillus casei on the organoleptic properties and on the growth of Staphylococcus aureus and Listeria monocytogenes during manufacturing, ripening and storage of Iranian white‐brined cheese
Sönmez et al. Determination of the relationship between oxalate degradation and exopolysaccharide production by different Lactobacillus probiotic strains
TW200700074A (en) Inducer of t cell apoptosis
UA99450C2 (ru) Штамм микроорганизма bacillus smithii tbmi12 mscl p737 и его функциональные эквиваленты (эндоспоры, мутанты, поколения, производные) для защиты от действия энтеропатогенных бактерий
EP1555028A4 (en) ANTI-ALLERGIC AGENT, USE THEREOF FOR REDUCING ALLERGIES AND METHOD OF REDUCING ALLERGIES
CA2567976A1 (en) A composition having immunoregulating activities comprising lactobacillus pentosus
SG178985A1 (en) Proliferation-enhancing agent and/or survivability-improving agent for lactic acid bacterium belonging to genus lactobacillus
KR20150075770A (ko) 혼합 유산균 스타터를 이용한 디톡스 활성 촉진용 과채 발효물 및 이의 이용
WO2021258073A3 (en) Compositions and methods for producing enhanced crops of brassicaceae family with probiotics
Duval et al. Effect of a blend of essential oil compounds on the colonization of starch‐rich substrates by bacteria in the rumen

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20101231

HC1A Change of owner name
GB1A Change in the ownership or in the address of the owner